Nuvation Bio, Inc.(NUVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NUVB Nuvation Bio, Inc.

Market Closed 10-16 16:00:00 EDT

4.45

-0.30

-6.32%

盘后4.46

+0.00+0.11%

19:58 EDT

High4.76	Low4.42	Vol4.47M
Open4.75	D1 Closing4.75	Amplitude7.16%
Mkt Cap1.56B	Tradable Cap1.17B	Total Shares351.12M
T/O20.16M	T/O Rate1.69%	Tradable Shares264.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NUVB","market":"US","secType":"STK","nameCN":"Nuvation Bio, Inc.","latestPrice":4.45,"timestamp":1792180800000,"preClose":4.75,"halted":0,"volume":4473381,"hourTrading":{"tag":"盘后","latestPrice":4.455,"preClose":4.45,"latestTime":"19:58 EDT","volume":161881,"amount":720385.0894,"timestamp":1792195082856,"change":0.005,"changeRate":0.001124,"amplitude":0.026809},"delay":0,"changeRate":-0.06315789473684207,"floatShares":264000000,"shares":351123233,"eps":-0.438679,"marketStatus":"Market Closed","change":-0.3,"latestTime":"10-16 16:00:00 EDT","open":4.75,"high":4.76,"low":4.42,"amount":20156173.529943,"amplitude":0.071579,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.438679,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1792396800000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":4.75,"preHourTrading":{"tag":"盘前","latestPrice":4.8,"preClose":4.75,"latestTime":"09:21 EDT","volume":258,"amount":1243.902624,"timestamp":1792156875813,"change":0.05,"changeRate":0.010526,"amplitude":0.014737},"postHourTrading":{"tag":"盘后","latestPrice":4.455,"preClose":4.45,"latestTime":"19:58 EDT","volume":161881,"amount":720385.0894,"timestamp":1792195082856,"change":0.005,"changeRate":0.001124,"amplitude":0.026809},"volumeRatio":1.0006889456371415,"impliedVol":1.9002,"impliedVolPercentile":0.9084},"requestUrl":"/m/hq/s/NUVB/wiki","defaultTab":"wiki","newsList":[{"id":"2675372786","title":"Our Pick Of The Best Penny Stocks In October 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2675372786","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675372786?lang=en_us&edition=fundamental","pubTime":"2026-10-15 10:34","pubTimestamp":1792031688,"startTime":"0","endTime":"0","summary":"When consumer prices rise faster than worker paychecks, every dollar has to work harder. That pressure often pushes investors to look beyond the crowded big-cap space and toward lower priced shares of financially sound smaller businesses that may offer more room for upside per dollar invested. This article zeroes in on three such lower priced stocks that pass strict balance sheet and cash discipline filters.\nThe three stocks highlighted here offer a compelling starting point if you want...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551730-choice2-card/1789070492827","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551730-choice2-card/1789070492827"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gdrx/goodrx-holdings/news/our-pick-of-the-best-penny-stocks-in-october-2026-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gdrx/goodrx-holdings/news/our-pick-of-the-best-penny-stocks-in-october-2026-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GDRX","LU2362540622.SGD","LU1242518931.SGD","BK4022","LU0979878070.USD","NUVB","LU0441851309.USD","SG9999013478.USD","GRAG","LU0210637038.USD",".IXIC","SG9999002406.SGD","SG9999013486.USD","LU2125910500.SGD","BK4007","SG9999002414.USD","GRAB","SGXZ58947870.SGD","LU1839390173.USD","SG9999002604.SGD","SG9999002679.SGD","BK4230","LU2045819591.USD","SG9999001135.SGD","BK4122","LU0532188223.SGD","BK4167","LU2362541513.USD","SG9999013460.SGD","SG9999002620.SGD","SG9999006266.SGD","LU1242518857.USD","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674877282","title":"3 Promising Penny Stocks With Market Caps Over $200M","url":"https://stock-news.laohu8.com/highlight/detail?id=2674877282","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674877282?lang=en_us&edition=fundamental","pubTime":"2026-10-12 19:04","pubTimestamp":1791803091,"startTime":"0","endTime":"0","summary":"In the last week, the market has stayed flat, but it is up 15% over the past year with expectations for earnings to grow by 18% per annum over the next few years. Though 'penny stocks' might sound like a relic of past trading days, they continue to offer potential opportunities for growth when backed by strong financials. We'll explore several penny stocks that could pair balance sheet strength with long-term potential, offering investors a chance to uncover hidden value in quality companies.","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/3-promising-penny-stocks-with-market-caps-over-200m","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/3-promising-penny-stocks-with-market-caps-over-200m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","HK0000500386.USD","BK4531","BK4588","MOMO","PMDE","BK4077","BK4539","VOTE","HK0000252160.HKD","DECU","RGLO","BK4585","BK4526","BK4509","NUVB","BK4532","VGFPF","BK4502","JOYT","BK4508","ZH","FEBU","HK0000252152.HKD","GXDW","BK4513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674869097","title":"Nuvation Bio And 2 Penny Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2674869097","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674869097?lang=en_us&edition=fundamental","pubTime":"2026-10-10 03:24","pubTimestamp":1791573869,"startTime":"0","endTime":"0","summary":"With the World Trade Organization now expecting global trade growth to more than double in 2026 on the back of heavy AI infrastructure spending, attention is drifting toward smaller US listed minnows that still keep their finances in decent shape. These low priced shares can offer exposure without leaning on heavy debt or fragile cash positions. This article walks through three such financially grounded penny stocks that may merit a closer look.\nThe three stocks covered below are just a...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/nuvation-bio-and-2-penny-stocks-to-watch-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/nuvation-bio-and-2-penny-stocks-to-watch-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0979878070.USD","NUVB","BK4139","SG9999002604.SGD","SG9999013478.USD","BK4022","LU2362541513.USD","LU0441851309.USD","LU1242518931.SGD","LU2362540622.SGD","LU2125910500.SGD","LU0532188223.SGD",".IXIC","LU0210637038.USD","OPK","GRAG","LU1242518857.USD","SG9999013486.USD","SG9999001135.SGD","BK4122","SG9999002406.SGD","SG9999002620.SGD","SG9999006266.SGD","SGXZ58947870.SGD","BK4007","LU1839390173.USD","SG9999013460.SGD","BK4230","BK4196","SG9999002679.SGD","SG9999002414.USD","GRAB","LU2362541273.HKD","LU2045819591.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673710006","title":"3 Penny Stocks With Revenue Growth Up To 60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673710006","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673710006?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:43","pubTimestamp":1791470597,"startTime":"0","endTime":"0","summary":"The World Trade Organization now expects global goods trade to grow 3.9% this year as AI related spending supports demand, even with Middle East supply shocks in the background. When trade keeps humming, smaller listed businesses with healthier balance sheets can be better placed to keep funding and operating. This article walks through three lower priced stocks that combine that potential upside with relatively stronger financial footing.\nThe three stocks below are just a starting sample...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/3-penny-stocks-with-revenue-growth-up-to-60-4","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/3-penny-stocks-with-revenue-growth-up-to-60-4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NUVB","QSU","SG9999013460.SGD",".IXIC","SG9999002406.SGD","SG9999002679.SGD","SGXZ58947870.SGD","LU1839390173.USD","BK4545","LU1242518857.USD","QSX","LU0441851309.USD","BK4122","BK4230","CTEC","BK4561","BK4022","BK4007","LU2045819591.USD","SG9999001135.SGD","BK4124","QS","SG9999013486.USD","GRAB","GRAG","LU2362541273.HKD","LU2362541513.USD","SG9999002414.USD","BK4551","SG9999013478.USD","SG9999002620.SGD","LU2362540622.SGD","LU0210637038.USD","LU2249611893.SGD","SG9999002604.SGD","SG9999006266.SGD","LU0823414478.USD","LU2125910500.SGD","LU0532188223.SGD","BK4540","LU0979878070.USD","LU1242518931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671207715","title":"Nuvation Bio Shares up 1% After Citigroup Initiates Coverage with Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2671207715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671207715?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:36","pubTimestamp":1790775371,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4N45M177:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671018872","title":"Nuvation Bio Gains After Citi Initiates with \"buy\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2671018872","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671018872?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:59","pubTimestamp":1790769555,"startTime":"0","endTime":"0","summary":"BUZZ-Nuvation Bio gains after Citi initiates with \"buy\"** Shares of cancer treatment firm Nuvation BioNUVB.Nrise 3.4% to $5.81 premarket** Citi initiates coverage with \"buy\" rating; PT $12** \"NUVB provides a compelling combination of a high growth commercial oncology franchise,\" says brokerage** Adds, \"NUVB provides a compelling combination of a high growth commercial oncology franchisewith an underappreciated late-stage pipeline opportunity\"** 11 of 12 brokerages rate the stock \"buy\" or higher, 1 \"hold\"; median PT is $13 - data compiled by LSEG** As of last close, shares down 37.3% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4N45M0WZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","LU2125154935.USD","LU1668664300.SGD","LU1244550577.SGD","NUVB","LU2456880835.USD","LU0477156953.USD","LU0980610538.SGD","LU0170899867.USD","LU0203347892.USD","IE00BSNM7G36.USD","LU0203345920.USD","LU0320765646.SGD","LU2236285917.USD","LU1791807156.HKD","LU1244550494.USD","FTXO","LU1506573853.SGD","LU0106831901.USD","LU0130102774.USD","LU0130517989.USD","LU0098860793.USD","LU1144417596.USD","LU0128525689.USD","LU0052756011.USD","BK4007","LU1162221912.USD","LU2360032135.SGD","LU2417539215.USD","LU1244550221.USD","LU0310800965.SGD","LU1074936037.SGD","LU1201861249.SGD","LU1366192091.USD","BK4566","BK4585","BK4559","LU0648001328.SGD","LU1267930227.SGD","LU0314106906.USD","BK4534","TFNS","IYF","LU0072461881.USD","LU2125154778.USD","LU0162691827.USD","BK4207","BK4588","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671203727","title":"Nuvation Bio Initiated at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2671203727","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671203727?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:32","pubTimestamp":1790764320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NUVB/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671810203","title":"Nuvation Bio Inc. : Citigroup Initiates Coverage with Buy Rating; Target Price $12","url":"https://stock-news.laohu8.com/highlight/detail?id=2671810203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671810203?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:14","pubTimestamp":1790763294,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nFWN45M0ET:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671203522","title":"Nuvation Bio initiated with a Buy at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2671203522","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671203522?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:10","pubTimestamp":1790763045,"startTime":"0","endTime":"0","summary":"Citi initiated coverage of Nuvation Bio (NUVB) with a Buy rating and $12 price target The firm views the company as an emerging oncology leader. Th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvation-bio-initiated-with-a-buy-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvation-bio-initiated-with-a-buy-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671582208","title":"Citigroup Initiates Nuvation Bio at Buy With $12 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2671582208","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671582208?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:55","pubTimestamp":1790762116,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) has an average rating of buy and mean price target of $13.10, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668996120","title":"Nuvation Bio announces FDA approval of sNDA for Ibtrozi","url":"https://stock-news.laohu8.com/highlight/detail?id=2668996120","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668996120?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:35","pubTimestamp":1789644932,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) announced that the U.S. FDA has approved a supplemental New Drug Application for Ibtrozi, a ROS1 inhibitor approved for the tre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvation-bio-announces-fda-approval-of-snda-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvation-bio-announces-fda-approval-of-snda-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","FRTY","XLVX","MRNX","IYH","MRNY","LFSC","RSPH","TBXU","GDOC","LABU","PINK","BK4585","IDNA","NVIB","GNMX","NUVB","TECB","IEIH","BBP","PSCH","MEDI","SYNB","BMED","IBB","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961130","title":"Nuvation Bio Wins FDA Nod to Update Ibtrozi Label with 49.7-Month Response Duration in TRUST-I Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961130","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961130?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:31","pubTimestamp":1789644689,"startTime":"0","endTime":"0","summary":"Nuvation Bio wins FDA nod to update IBTROZI label with 49.7-month response duration in TRUST-I studyNuvation Bio secured FDA clearance for a supplemental filing updating IBTROZI’s label in ROS1-positi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL8JXhYH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961985","title":"Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for Ibtrozi® (Taletrectinib) with Updated Duration of Response in Tki-NaÏVe Advanced Ros1-Positive Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961985","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961985?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:30","pubTimestamp":1789644601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nTUA6VYG0S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668953961","title":"Nuvation Bio - no Changes to Ibtrozi Safety Labeling; no New Safety Signals Identified","url":"https://stock-news.laohu8.com/highlight/detail?id=2668953961","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668953961?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:30","pubTimestamp":1789644601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nTUA6VYG0S:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667398322","title":"Nuvation Bio Price Target Maintained with a $11.00/Share by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2667398322","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667398322?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:34","pubTimestamp":1789562040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NUVB/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664495938","title":"Nuvation Bio CEO, CFO to Present at Citi Biopharma Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664495938","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664495938?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:07","pubTimestamp":1788379646,"startTime":"0","endTime":"0","summary":"Nuvation Bio CEO, CFO to present at Citi biopharma conference fireside chatNuvation Bio executives plan investor fireside chats at Citi’s 2026 Biopharma Back to School Conference on Sept. 9, 2026.Mana","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL7xm2jG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314106906.USD","LU0477156953.USD","LU0310800965.SGD","LU1791807156.HKD","LU2360032135.SGD","TFNS","LU0980610538.SGD","LU0128525689.USD","LU1244550221.USD","LU2417539215.USD","LU1244550577.SGD","BK4207","BK4007","FTXO","LU0162691827.USD","LU0052756011.USD","BK4559","LU1144417596.USD","LU0203345920.USD","LU1668664300.SGD","LU1162221912.USD","LU2456880835.USD","LU0320765646.SGD","LU2236285917.USD","LU1201861249.SGD","LU1267930227.SGD","LU0648001328.SGD","LU0170899867.USD","LU0106831901.USD","LU1074936037.SGD","IE00BSNM7G36.USD","BK4588","LU1506573853.SGD","LU2125154778.USD","IYF","LU0098860793.USD","BK4566","LU0130102774.USD","LU0130517989.USD","LU1366192091.USD","NUVB","LU0072461881.USD","LU2125154935.USD","LU2462157665.USD","BK4534","LU0203347892.USD","BK4585","LU1244550494.USD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661029080","title":"Nuvation Bio CSO Gary Hattersley Disposes of Class a Common Shares Worth $709,240","url":"https://stock-news.laohu8.com/highlight/detail?id=2661029080","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661029080?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:50","pubTimestamp":1787345436,"startTime":"0","endTime":"0","summary":"Nuvation Bio CSO Gary Hattersley disposes of Class A common shares worth $709,240Nuvation Bio Chief Scientific Officer Gary Hattersley exercised stock options for 100,000 Class A common shares on Aug.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDLbNXgFb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Nuvation Bio CSO Gary Hattersley Disposes of Class a Common Shares Worth $709,240","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661647812","title":"Cantor Fitzgerald Initiates Nuvation Bio at Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2661647812","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661647812?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:35","pubTimestamp":1787308556,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) has an average rating of buy and mean price target of $13.10, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661264632","title":"Nuvation Bio Initiated at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2661264632","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661264632?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:24","pubTimestamp":1787307840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NUVB/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661264610","title":"Nuvation Bio initiated with an Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2661264610","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661264610?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:10","pubTimestamp":1787307023,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald initiated coverage of Nuvation Bio (NUVB) with an Overweight rating and no price target The firm views Nuvation as a “low-risk, h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvation-bio-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvation-bio-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.11},{"period":"1month","weight":-0.2301},{"period":"3month","weight":-0.2328},{"period":"6month","weight":-0.124},{"period":"1year","weight":0.2259},{"period":"ytd","weight":-0.5033}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1193}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung , M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco .","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.099824},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.044723},{"month":3,"riseRate":0.5,"avgChangeRate":0.083814},{"month":4,"riseRate":0.5,"avgChangeRate":0.010626},{"month":5,"riseRate":0.666667,"avgChangeRate":0.014611},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.044383},{"month":7,"riseRate":0.666667,"avgChangeRate":0.074},{"month":8,"riseRate":0.666667,"avgChangeRate":0.020101},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.055485},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.043521},{"month":11,"riseRate":0.5,"avgChangeRate":0.163132},{"month":12,"riseRate":0.666667,"avgChangeRate":0.061496}],"exchange":"NYSE","name":"Nuvation Bio, Inc.","nameEN":"Nuvation Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nuvation Bio, Inc.(NUVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Nuvation Bio, Inc.(NUVB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Nuvation Bio, Inc.,NUVB,Nuvation Bio, Inc.股票,Nuvation Bio, Inc.股票老虎,Nuvation Bio, Inc.股票老虎国际,Nuvation Bio, Inc.行情,Nuvation Bio, Inc.股票行情,Nuvation Bio, Inc.股价,Nuvation Bio, Inc.股市,Nuvation Bio, Inc.股票价格,Nuvation Bio, Inc.股票交易,Nuvation Bio, Inc.股票购买,Nuvation Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nuvation Bio, Inc.(NUVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Nuvation Bio, Inc.(NUVB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction